RA
SRTA

Ramius Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Ramius Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-82,400
Closed -$828K – 112
2020
Q3 		$828K Buy
+82,400
New +$832K 0.2% 52

Other funds holding SRTA

HVCM
HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
RA
RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Ramius Advisors's SRTA Position: Q4 2020 in Review

Ramius Advisors sold out of Strata Critical Medical Inc (SRTA) in Q4 2020, closing a stake of 82,400 shares — an estimated $828K sold.

Ramius Advisors first reported a position in SRTA in Q3 2020 and held it in 1 quarter. The position peaked at $828K in Q3 2020. 84 funds tracked by Wall St. Rank hold SRTA as of Q4 2020.

  • Ramius Advisors reported no remaining Strata Critical Medical Inc position as of Q4 2020 after selling out during the quarter.
  • Ramius Advisors sold 82,400 Strata Critical Medical Inc shares in Q4 2020, an estimated $828K.
  • Ramius Advisors first reported a position in Strata Critical Medical Inc in Q3 2020 and held it in 1 quarter.
  • Ramius Advisors's Strata Critical Medical Inc position peaked at $828K in Q3 2020.
  • 84 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2020.

Based on Ramius Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.